The role of β-lactam/β-lactamase inhibitors in the management of mixed infections

This publication has 22 references indexed in Scilit:

• Ampicillin/Sulbactam versus Cef otetan for the Prevention of Infection following Cesarean Delivery in High-Risk Patients: A Randomized Double-Blind Trial
  Gynecologic and Obstetric Investigation, 1997
• Cost-Effectiveness of Ampicillin/Sulbactam Versus Imipenem/Cilastatin in the Treatment of Limb-Threatening Foot Infections in Diabetic Patients
  Clinical Infectious Diseases, 1997
• Perioperative use of ampicillin/sulbactam, cefoxitin and piperacillin/metronidazole in elective colon and rectum surgery: a prospective and randomized quality control study in 422 patients
  International Journal of Antimicrobial Agents, 1996
• Use of Ampicillin/Sulbactam Versus Imipenem/Cilastatin in the Treatment of Limb-Threatening Foot Infections in Diabetic Patients
  Clinical Infectious Diseases, 1994
• ABDOMINAL SURGICAL WOUND INFECTION IS LOWERED WITH IMPROVED PERIOPERATIVE ENTEROCOCCUS AND BACTEROIDES THERAPY
  Published by Wolters Kluwer Health ,1993
• Efficacy of a β-Lactamase Inhibitor Combination for Serious Intra-abdominal Infections
  Annals of Surgery, 1993
• Microbiology, Chemotherapy and Mortality of Brain Abscess in Newcastle-upon-Tyne between 1979 and 1988
  Scandinavian Journal of Infectious Diseases, 1990
• Sulbactam/Ampicillin: In Vitro Spectrum, Potency, and Activity in Models of Acute Infection
  Clinical Infectious Diseases, 1986
• Pathophysiology and management of postcesarean endomyometritis
  Obstetrics & Gynecology, 1986
• Concentration of Sulbactam and Ampicillin in Serum and the Myometrium
  Drugs, 1986